We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Upholds Dismissal of Mylan's Suit Against FDA, Watson, P&G
Court Upholds Dismissal of Mylan's Suit Against FDA, Watson, P&G
August 2, 2006
A federal appeals court has affirmed the dismissal of a lawsuit filed by Mylan Pharmaceuticals against the FDA, Watson Pharmaceuticals and Procter & Gamble (P&G) after the agency allowed the two drugmakers to market an authorized version of P&G’s urinary tract infection drug Macrobid during Mylan’s 180-day marketing exclusivity.